Home›Companies›Biotech & Pharma›SeQure Dx

SeQure Dx Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 22, 2023·Suggest an edit

About SeQure Dx

SeQure Dx is a private company based in Waltham, Massachusetts, incorporated in 2020 in Delaware. It has reported $22,290,322 raised in three offerings on Form D since April 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 21, 2023Dec 22, 2023$2,177,419of $5.0M target7$311KDebt, OptionsRule 506(b)Form D ↗
Jun 22, 2023Dec 22, 2023$2,612,903of $8.0M target7$373KDebt, OptionsRule 506(b)Form D ↗
Mar 24, 2021Apr 6, 2021$17,500,000fully sold9$1.9MEquityRule 506(b)Form D ↗
Total, three offerings$22,290,322

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on SeQure Dx's Form D filed Dec 22, 2023.

CB
Carl Berke
Director
IZ
Isaac Zike
Director
SP
Sanjay Pothen
President and director

Earlier filings also listed Nancy Hong (director, last listed Dec 2023) and Ellen Sheets (executive officer and director, last listed Dec 2023).

Sources

  1. SECSeQure Dx Inc. filing history